GDOC GOLDMAN SACHS FUTURE HEALTH CARE EQUITY ETF
- 34.590
- -0.070-0.20%
$1000 Invested In This Stock 5 Years Ago Would Be Worth $2,000 Today
AbbVie (NYSE:ABBV) has outperformed the market over the past 5 years by 1.96% on an annualized basis producing an average annual return of 15.08%. Currently, AbbVie has a market capitalization of $288
Eli Lilly's Weekly Insulin Dose On Par With Commonly Used Daily Doses, Phase 3 Studies Show
Eli Lilly and Co (NYSE:LLY) released Thursday topline results from two phase 3 trials. The drugmaker evaluated once-weekly insulin efsitora alfa (efsitora) in type 2 diabetes patients using insulin fo
Novo Nordisk Falls on Reports of Fire at Construction Site
Eli Lilly's QWINT-2 And QWINT-4 Phase 3 Trials Of Once-weekly Insulin Efsitora In Type 2 Diabetes Patients Using Insulin For First Time And Require Multiple Daily Injections, Efsitora Showed Non-Inferior A1C Reduction Vs. Most Commonly Used Daily Insulin
Efsitora met the primary endpoint in both QWINT-2 and QWINT-4 with once-a-week dosing regimen for people living with type 2 diabetesEfsitora was equally safe and effective among adults naïve to insul
Roche Obesity Therapy Leads to ~19% Weight Loss in Phase 1 Trial
Duquesne Family Office Top Q1 Buys, Cuts: Coherent, Eli Lilly, Others
'3F Shows ValueAct Dissolves Stake In Seagate, Danaher
'3F Shows ValueAct Dissolves Stake In Seagate, Danaher
S&P 500, Nasdaq 100, Dow Jones Shatter Record Highs In Unstoppable Bull Market Rally
The S&P 500, Nasdaq 100 and Dow Jones Industrial Average indices all shattered fresh all-time highs Wednesday, driven by a benign inflation report that boosted risk sentiment among bullish investors.T
10 Health Care Stocks With Whale Alerts In Today's Session
This whale alert can help traders discover the next big trading opportunities.
What's Going On With NVIDIA Stock Today?
NVIDIA Corporation (NASDAQ:NVDA) shares are trading higher on Wednesday.In a blog post, the company said that a collaboration between NVIDIA and academic researchers is prepping robots for surgery.ORB
$100 Invested In Intuitive Surgical 10 Years Ago Would Be Worth This Much Today
Intuitive Surgical (NASDAQ:ISRG) has outperformed the market over the past 10 years by 14.72% on an annualized basis producing an average annual return of 25.62%.
No Wegovy Shortage in Denmark Amid High Demand, Novo Nordisk Confirms
Novo Nordisk A/S (NYSE:NVO) says that despite earlier warnings from the Danish Medicines Agency about potential shortages of Wegovy, it does not anticipate a shortage of its weight-loss drug in Denmar
Least Shorted S&P 500 Stocks as a Percentage of Float
Short Interest in S&P 500 Healthcare Sector Dips in April, Biotechnology Companies Most Shorted
Novo Nordisk Owner to Acquire Major Stake in Australian Life Sciences Firm
Decoding 18 Analyst Evaluations For Boston Scientific
Providing a diverse range of perspectives from bullish to bearish, 18 analysts have published ratings on Boston Scientific (NYSE:BSX) in the last three months.The following table provides a quick over
Boston Scientific Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/15/2024 22.47% Mizuho $85 → $90 Maintains Buy 04/26/2024 6.14% Barclays $70 → $78 Maintains Overweight
Qiaoshui's Q1 favors technology stocks! Newly opened warehouses with Amazon and AMD, Pinduoduo and P&G have continuously reduced their holdings
Amazon was Qiaoshui's largest newly opened stock in the first quarter. After almost clearing its inventory last year, Apple's holdings were greatly increased again, and Pinduoduo and P&G's holdings were reduced for several consecutive quarters.
Eli Lilly Provides Update On Mounjaro And Zepbound Compounding Litigation; Enters Settlement Requiring Totality Medispa To Make Monetary Payment, Prohibiting Misleading Conduct, And Reporting Adverse Events To FDA
Eli Lilly Provides Update On Mounjaro And Zepbound Compounding Litigation; Enters Settlement Requiring Totality Medispa To Make Monetary Payment, Prohibiting Misleading Conduct, And Reporting Adverse
'Lawmaker Accuses Amgen of Placing Profits Above Patients With Dosing for a Cancer Drug' -STAT News
'Lawmaker Accuses Amgen of Placing Profits Above Patients With Dosing for a Cancer Drug' -STAT News